The validity period for the approval for 50 active substances has been extended by one year due to the delay in the re-evaluation following the application for renewal of the approval. We list the organic active ingredients only.
If the review for any of the active ingredients leads to rejection of the renewal application in the meantime, the approval will expire with a corresponding order ahead of schedule.
The lifetime extensions have no influence on the current maximum residue limits.
Active Ingredients |
Limited until |
Reference |
Buprofezin |
01/31/2024 |
1) |
Metiram * |
||
Mecoprop-P * |
||
Pyraclostrobin * |
||
Fluazinam * |
02/29/2024 |
|
Flutolanil * |
||
Mepiquat * |
||
Benzovindiflupyr |
03/02/2024 |
|
Cyflufenamid |
03/31/2024 |
|
Lambda-Cyhalothrin |
||
Metsulfuron-methyl |
||
Phosphane |
||
Dimoxystrobin |
01/31/2024 |
2) |
Oxamyl |
10/31/2023 |
3) |
*For these active substances, an assessment as potential endocrine disruptors is also pending.
Author: Dr. Frank Mörsberger